As the world continues to grapple with the coronavirus pandemic, a popular program that aims to assess the manufacturing maturity of medical device firms is soldiering on.
The Case for Quality Voluntary Improvement Program – or CFQ VIP – is run jointly by the US Food and Drug Administration and the Medical Device Innovation Consortium (MDIC). It aims to elevate product, manufacturing and process quality at device firms by appraising the companies against an industry-modified version of the Capability Maturity Model Integration (CMMI) framework
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?